The NHS Diabetic Eye Screening (DES) Programme helps prevent sight loss in people with diabetes. Screening can detect diabetic retinopathy early, when treatment is effective at reducing or preventing damage from the condition.
Dr Peter Scanlon
Dr Peter Scanlon is Clinical Director of the NHS Diabetic Eye Screening Programme. With the support and co-operation of colleagues, he helped move screening from limited ad hoc delivery of services to a systematic quality assured programme for all people with diabetes aged 12 and over in England. He is a Senior Research Fellow and Medical Tutor at Harris Manchester College, University of Oxford, and Visiting Professor at the University of Gloucestershire.
Related content and links
PHE Screening has paused its social media accounts while staff support the national response to Covid-19.
Any queries in relation to the provision of screening programmes during the COVID-19 response can be made to the NHSEI Incident Control Team.
The PHE Screening team
Public Health England (PHE) is the expert voice on screening, providing advice and guidance to the NHS. The national population screening programmes identify apparently healthy people who may be at increased risk of a disease or condition, enabling earlier treatment and informed decisions.
Find out more about PHE Screening and this blog.
Watch our 44 second video for an overview of how the blog works.